'A DEXA Scan Is Just for Bone Density': The Body-Composition Data a Strength-Seeker Is Leaving on the Table at 47

You booked the DEXA scan for a bone number, walked out with a T-score, and filed the rest away. If you train seriously and you are in your late forties, that report holds far more than skeletal data, and most of it maps directly onto how you build and hold strength.

This is educational information, not medical advice. What follows is meant to help you ask sharper questions, not to diagnose anything or point you toward a specific drug.

The scan you already trust does three jobs, not one

Dual-energy X-ray absorptiometry (DEXA, or DXA) works by passing two low-dose X-ray energies through the body and measuring how each tissue attenuates them. Bone, lean soft tissue, and fat absorb the two energies differently, which lets the software separate them ^[1]. Bone mineral density is the output most people know, and it is genuinely important: it is the reference standard for diagnosing osteoporosis and estimating fracture risk ^[2].

But the same acquisition also produces a three-compartment body-composition breakdown: bone mineral, lean soft tissue, and fat mass, reported both for the whole body and by region (arms, legs, trunk, android, gynoid). For someone trying to stay strong through midlife, the lean and regional data are arguably the most actionable numbers on the page, and they are frequently ignored.

Lean mass and appendicular lean mass: the strength conversation

Sarcopenia, the age-related loss of muscle mass and function, is not a distant concern. Muscle mass tends to decline gradually from mid-adulthood, and DXA is one of the recommended tools for quantifying it ^[3]. The metric to look for is appendicular lean mass (ALM), the lean soft tissue in the arms and legs, which is often normalized to height squared to give an appendicular lean mass index.

Why the limbs? Because appendicular lean tissue is dominated by skeletal muscle, so it tracks the tissue that actually moves load. The European Working Group on Sarcopenia in Older People and related consensus efforts use ALM thresholds as part of how low muscle mass is defined ^[4]. For a lifelong lifter, a single ALM value is a baseline; the more useful signal is the trajectory over time and how it lines up with what you feel in the gym, such as longer recovery windows and slower session-to-session bounce-back.

A scan cannot tell you why lean mass is trending a certain way. It can tell an independent provider where to look, and it turns a vague sense of "something shifted" into a number that can be tracked.

Visceral adipose tissue: the metabolic flag hiding in the trunk

Modern DXA software also estimates visceral adipose tissue (VAT), the metabolically active fat packed around the abdominal organs, distinct from the subcutaneous fat under the skin. This matters because VAT, not total body fat, is the fat depot most strongly linked to cardiometabolic risk ^[5]. Two people can weigh the same, wear the same size, and carry very different visceral loads.

The perimenopausal transition is relevant here. Research using longitudinal cohorts has documented that the menopause transition is associated with a shift in fat distribution toward the trunk and abdomen, independent of aging and overall weight change ^[6]. That is not a moral failing or a training error; it is a measurable physiological shift, and it is exactly the kind of thing a good clinician takes seriously rather than waving off as "normal aging."

A DEXA-derived VAT estimate gives an independent provider an objective data point to pair with labs like fasting glucose, a lipid panel, and markers of insulin sensitivity, instead of guessing from a scale weight.

Regional distribution: the asymmetries a lifter should see

Because DXA reports lean and fat by region, it can surface left-versus-right and upper-versus-lower asymmetries. For a physical therapist, this is familiar territory: a lingering side dominance after an old injury, or a lower-body lean deficit relative to the upper body, can be quantified rather than eyeballed. These regional numbers do not diagnose anything on their own, but they give context that a whole-body average erases.

Putting the report in front of the right person

Here is the practical shift. A DEXA report read only for its T-score is a bone screen. The same report, read alongside your symptoms and the right labs, becomes an input into a midlife strength and metabolic picture. The labs that often accompany this kind of review include a comprehensive metabolic panel, lipids, HbA1c or fasting insulin, thyroid studies, vitamin D, and, where clinically appropriate and requested, sex-hormone and related markers. Which labs get ordered, and how they are interpreted, is a decision for an independent licensed provider based on your history and goals, not a checklist to self-order.

On the interventions you may have read about: resistance training and adequate protein intake are the foundation of preserving lean mass with age, and that evidence base is strong ^[3]. Some people also ask about hormone-related options or peptide therapies. Those are prescription-level, individualized decisions. If compounded medications ever enter the conversation, it is worth knowing this up front: compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state. Whether any medication is appropriate, and whether a prescription is issued at all, is determined solely by an independent licensed provider, and a prescription is never guaranteed.

What to bring to the review

• The full DEXA report, not just the bone-density summary, including lean mass, ALM, VAT, and regional breakdowns.
• A training log or honest notes on recovery, sleep, and session quality over recent months.
• Prior labs if you have them, so trajectory (not a single snapshot) can be assessed.

The goal is partnership: an informed reader and an independent provider looking at the same objective data and deciding what, if anything, is worth acting on.

Where Velri fits

Velri is a technology and coordination company, not a medical practice. Velri does not provide medical care and employs no physicians. What Velri can do is coordinate the logistics: help arrange appropriate lab work, connect you with an independent, physician-led Provider Group for a visit where your data and goals are reviewed, and, if and only if a provider prescribes something, route that prescription to an independent, licensed pharmacy. Care and prescribing decisions are made entirely by independent licensed providers, and any medication is dispensed by independent pharmacies. Coverage currently starts in Nevada, with more states rolling out over time. Nothing here is a promise of treatment or an outcome; it is coordination around a conversation you deserve to have with the right person looking at the right data.